These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 16860657

  • 1. Cancer vaccines: preclinical studies and novel strategies.
    Palena C, Abrams SI, Schlom J, Hodge JW.
    Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
    [Abstract] [Full Text] [Related]

  • 2. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R.
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [Abstract] [Full Text] [Related]

  • 3. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM, Del Prete G, Amedei A.
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [Abstract] [Full Text] [Related]

  • 4. T-cell epitope peptide vaccines.
    Elsawa SF, Rodeberg DA, Celis E.
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current developments in cancer vaccines and cellular immunotherapy.
    Ribas A, Butterfield LH, Glaspy JA, Economou JS.
    J Clin Oncol; 2003 Jun 15; 21(12):2415-32. PubMed ID: 12805342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA.
    Nature; 2001 May 17; 411(6835):380-4. PubMed ID: 11357146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM, Draghia-Akli R.
    Expert Rev Vaccines; 2008 Sep 17; 7(7):1085-101. PubMed ID: 18767956
    [Abstract] [Full Text] [Related]

  • 13. Cancer vaccines: Where are we going?
    Cebon J.
    Asia Pac J Clin Oncol; 2010 Mar 17; 6 Suppl 1():S9-15. PubMed ID: 20482531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B.
    Bull Mem Acad R Med Belg; 2007 Mar 17; 162(5-6):352-6. PubMed ID: 18405005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cancer vaccines: challenges and outlook in the field.
    Paul S, Acres B, Limacher JM, Bonnefoy JY.
    IDrugs; 2007 May 17; 10(5):324-8. PubMed ID: 17487784
    [Abstract] [Full Text] [Related]

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 17; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 20. Development of optimized cryptic peptides for immunotherapy.
    Menez-Jamet J, Kosmatopoulos K.
    IDrugs; 2009 Feb 17; 12(2):98-102. PubMed ID: 19204883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.